Log on / register
Feedback | Support | My details

Pre-publication history

Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort

Carlo Torti email, Giuseppe Lapadula email, Salvatore Casari email, Massimo Puoti email, Mark Nelson email, Eugenia Quiros-Roldan email, Daniele Bella email, Giuseppe Pastore email, Nicoletta Ladisa email, Lorenzo Minoli email, Giovanni Sotgiu email, Francesco Mazzotta email, Sergio Lo Caputo email, Giovanni Di Perri email, Gaetano Filice email, Carmine Tinelli email, Giampiero Carosi email and the EPOKA-MASTER Study Group email

BMC Infectious Diseases 2005, 5:58doi:10.1186/1471-2334-5-58

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript01 Feb 2005
Reviewer's ReportJuan Macías21 Feb 2005
Reviewer's ReportUberti-Foppa Caterina25 Feb 2005
Reviewer's ReportUlrich Spengler02 Mar 2005
Reviewer's ReportBendix Carstensen08 Mar 2005
Resubmission - Version 2Manuscript11 Apr 2005
Resubmission - Version 3ManuscriptAuthors' comments11 Apr 2005
Reviewer's ReportUlrich Spengler20 Apr 2005
Reviewer's ReportJuan Macías25 Apr 2005
Reviewer's ReportUberti-Foppa Caterina26 Apr 2005
Reviewer's ReportBendix Carstensen04 May 2005
Resubmission - Version 4Manuscript03 Jun 2005
Resubmission - Version 5Manuscript20 Jun 2005
Reviewer's ReportBendix Carstensen06 Jul 2005
Resubmission - Version 7ManuscriptAuthors' comments14 Jul 2005
Accepted14 Jul 2005
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.